Wang Yan, Gao Wan, Wang Xiao-Juan
Department of Obstetrics and Gynaecology, Xi'an Central Hospital, Xi'an 710003, Shaanxi Province, China.
World J Clin Cases. 2024 Jun 26;12(18):3378-3384. doi: 10.12998/wjcc.v12.i18.3378.
Insulin injection is the basic daily drug treatment for diabetic patients.
To evaluate the comparative impacts of continuous subcutaneous insulin infusion (CSII).
Based on the treatment modality received, the patients were allocated into two cohorts: The CSII group and the multiple daily injections (MDI) group, with each cohort comprising 210 patients. Comparative assessments were made regarding serum levels of serum-secreted frizzled-related protein 5, homocysteine, and C1q/TNF-related protein 9. Furthermore, outcomes such as fasting plasma glucose, 2-hour postprandial glucose levels, pain assessment scores, and the incidence of complications were evaluated post-treatment.
The CSII group displayed notably lower fasting plasma glucose and 2-h postprandial glucose levels in comparison to the MDI group ( < 0.05). Subsequent analysis post-treatment unveiled a significantly higher percentage of patients reporting no pain in the CSII group (60.00%) in contrast to the MDI group (36.19%) ( < 0.05). Additionally, the CSII group exhibited a markedly reduced occurrence of fetal distress and premature rupture of membranes compared to the MDI group ( < 0.05). However, there were no significant variances observed in other pregnancy outcomes between the two groups ( > 0.05). A statistical analysis revealed a significant difference in the incidence of complications between the groups ( = 11.631, = 0.001).
The utilization of CSII an insulin pump, as opposed to MDI, can significantly enhance the management of insulin administration in patients with GDM by diversifying the sites of insulin delivery. This approach not only promotes optimal glycemic control but also regulates metabolic factors linked to blood sugar, reducing the likelihood of adverse pregnancy outcomes and complications. The clinical relevance and importance of CSII in GDM management highlight its wide-ranging clinical usefulness.
胰岛素注射是糖尿病患者日常基本的药物治疗方法。
评估持续皮下胰岛素输注(CSII)的比较影响。
根据接受的治疗方式,将患者分为两组:CSII组和多次皮下注射(MDI)组,每组各有210名患者。对血清分泌型卷曲相关蛋白5、同型半胱氨酸和C1q/TNF相关蛋白9的血清水平进行比较评估。此外,在治疗后评估空腹血糖、餐后2小时血糖水平、疼痛评估评分和并发症发生率等结果。
与MDI组相比,CSII组的空腹血糖和餐后2小时血糖水平显著更低(<0.05)。治疗后的后续分析显示,与MDI组(36.19%)相比,CSII组报告无疼痛的患者百分比显著更高(60.00%)(<0.05)。此外,与MDI组相比,CSII组胎儿窘迫和胎膜早破的发生率显著降低(<0.05)。然而,两组之间在其他妊娠结局方面未观察到显著差异(>0.05)。统计分析显示两组之间并发症发生率存在显著差异(=11.631,=0.001)。
与MDI相比,使用CSII(胰岛素泵)可通过使胰岛素给药部位多样化,显著改善妊娠期糖尿病(GDM)患者的胰岛素管理。这种方法不仅促进最佳血糖控制,还调节与血糖相关的代谢因子,降低不良妊娠结局和并发症的可能性。CSII在GDM管理中的临床相关性和重要性凸显了其广泛的临床实用性。